Full Press Release Details
CAMBRIDGE, Mass. , Jan. 4, 2022 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL ), a biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter , Ph.D., Chief Executive Officer, will present at the 40 th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 , at 11:15 a.m. ET .
A live webcast will be available in the investor section of the company's website at www.nuvalent.com , and archived for 30 days following the presentation.
SOURCE Nuvalent, Inc.